HK1253244A1 - 使用受刺激的胎盤幹細胞的血管生成 - Google Patents
使用受刺激的胎盤幹細胞的血管生成Info
- Publication number
- HK1253244A1 HK1253244A1 HK18112530.2A HK18112530A HK1253244A1 HK 1253244 A1 HK1253244 A1 HK 1253244A1 HK 18112530 A HK18112530 A HK 18112530A HK 1253244 A1 HK1253244 A1 HK 1253244A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- angiogenesis
- stem cells
- placental stem
- stimulated placental
- stimulated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3808—Endothelial cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2301—Interleukin-1 (IL-1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2306—Interleukin-6 (IL-6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2308—Interleukin-8 (IL-8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2318—Interleukin-18 (IL-18)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/25—Tumour necrosing factors [TNF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
- C12N2502/025—Coculture with; Conditioned medium produced by embryonic cells extra-embryonic cells, e.g. amniotic epithelium, placental cells, Wharton's jelly
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Botany (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Microbiology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Inorganic Chemistry (AREA)
- Neurology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562166504P | 2015-05-26 | 2015-05-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1253244A1 true HK1253244A1 (zh) | 2019-06-14 |
Family
ID=57393645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18112530.2A HK1253244A1 (zh) | 2015-05-26 | 2018-09-28 | 使用受刺激的胎盤幹細胞的血管生成 |
Country Status (17)
Country | Link |
---|---|
US (2) | US20180298328A1 (zh) |
EP (1) | EP3310173A4 (zh) |
JP (3) | JP2018520209A (zh) |
KR (1) | KR20180012793A (zh) |
CN (2) | CN108366567A (zh) |
AU (3) | AU2016268322A1 (zh) |
BR (1) | BR112017025447A2 (zh) |
CA (1) | CA2987276A1 (zh) |
CO (1) | CO2017013361A2 (zh) |
EA (1) | EA201792603A1 (zh) |
HK (1) | HK1253244A1 (zh) |
IL (1) | IL255879A (zh) |
MX (1) | MX2017015147A (zh) |
NZ (1) | NZ737556A (zh) |
SG (1) | SG10201911179WA (zh) |
WO (1) | WO2016191449A1 (zh) |
ZA (1) | ZA201707906B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017058838A1 (en) * | 2015-09-29 | 2017-04-06 | Anthrogenesis Corporation | Cell potency assay |
WO2019177269A1 (ko) * | 2018-03-16 | 2019-09-19 | 주식회사 메디노 | 신경줄기세포를 이용한 혈관형성 유도 방법 |
JP2022513164A (ja) * | 2018-11-30 | 2022-02-07 | セルラリティ インク. | 胎盤由来同種car-t細胞およびその使用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2556145T1 (sl) * | 2010-04-07 | 2017-01-31 | Anthrogenesis Corporation | Angiogeneza z uporabo placentnih matičnih celic |
WO2012051210A2 (en) * | 2010-10-11 | 2012-04-19 | The Administrators Of The Tulane Educational Fund | Mesenchymal stem cells and related therapies |
ES2599331T3 (es) * | 2010-12-17 | 2017-02-01 | Anthrogenesis Corporation | Tratamiento de enfermedades y trastornos relacionados con el sistema inmunitario usando células adherentes derivadas del amnios |
US20120171180A1 (en) * | 2010-12-30 | 2012-07-05 | Sascha Abramson | Compositions comprising amnion derived adherent cells and platelet-rich plasma |
US8709401B2 (en) * | 2011-02-25 | 2014-04-29 | Howmedica Osteonics Corp. | Primed stem cells and uses thereof to treat inflammatory conditions in joints |
-
2016
- 2016-05-25 BR BR112017025447A patent/BR112017025447A2/pt not_active Application Discontinuation
- 2016-05-25 AU AU2016268322A patent/AU2016268322A1/en not_active Abandoned
- 2016-05-25 NZ NZ737556A patent/NZ737556A/en unknown
- 2016-05-25 JP JP2018513731A patent/JP2018520209A/ja active Pending
- 2016-05-25 MX MX2017015147A patent/MX2017015147A/es unknown
- 2016-05-25 EP EP16800648.4A patent/EP3310173A4/en not_active Withdrawn
- 2016-05-25 CN CN201680043819.3A patent/CN108366567A/zh active Pending
- 2016-05-25 CN CN202211221741.3A patent/CN115478043A/zh active Pending
- 2016-05-25 US US15/576,810 patent/US20180298328A1/en not_active Abandoned
- 2016-05-25 SG SG10201911179WA patent/SG10201911179WA/en unknown
- 2016-05-25 EA EA201792603A patent/EA201792603A1/ru unknown
- 2016-05-25 KR KR1020177037124A patent/KR20180012793A/ko not_active Application Discontinuation
- 2016-05-25 CA CA2987276A patent/CA2987276A1/en active Pending
- 2016-05-25 WO PCT/US2016/034003 patent/WO2016191449A1/en active Application Filing
-
2017
- 2017-11-21 ZA ZA2017/07906A patent/ZA201707906B/en unknown
- 2017-11-23 IL IL255879A patent/IL255879A/en unknown
- 2017-12-22 CO CONC2017/0013361A patent/CO2017013361A2/es unknown
-
2018
- 2018-09-28 HK HK18112530.2A patent/HK1253244A1/zh unknown
-
2021
- 2021-01-07 US US17/143,866 patent/US20210230537A1/en active Pending
- 2021-04-07 JP JP2021065437A patent/JP2021104053A/ja active Pending
- 2021-11-04 AU AU2021261923A patent/AU2021261923A1/en not_active Abandoned
-
2023
- 2023-04-12 JP JP2023064602A patent/JP2023089121A/ja active Pending
- 2023-11-29 AU AU2023274138A patent/AU2023274138A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
SG10201911179WA (en) | 2020-01-30 |
EA201792603A1 (ru) | 2018-06-29 |
BR112017025447A2 (pt) | 2018-11-06 |
CO2017013361A2 (es) | 2018-03-28 |
AU2021261923A1 (en) | 2021-12-02 |
EP3310173A1 (en) | 2018-04-25 |
WO2016191449A1 (en) | 2016-12-01 |
EP3310173A4 (en) | 2019-02-20 |
AU2016268322A1 (en) | 2017-12-21 |
ZA201707906B (en) | 2019-07-31 |
NZ737556A (en) | 2022-11-25 |
MX2017015147A (es) | 2018-03-28 |
JP2021104053A (ja) | 2021-07-26 |
JP2023089121A (ja) | 2023-06-27 |
US20210230537A1 (en) | 2021-07-29 |
US20180298328A1 (en) | 2018-10-18 |
CA2987276A1 (en) | 2016-12-01 |
CN108366567A (zh) | 2018-08-03 |
AU2023274138A1 (en) | 2023-12-21 |
IL255879A (en) | 2018-01-31 |
CN115478043A (zh) | 2022-12-16 |
KR20180012793A (ko) | 2018-02-06 |
JP2018520209A (ja) | 2018-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL274903A (en) | cell | |
HK1246825A1 (zh) | 細胞 | |
HK1252162A1 (zh) | 細胞 | |
HK1250667A1 (zh) | 細胞 | |
GB201507368D0 (en) | Cell | |
GB201503500D0 (en) | Cell | |
GB201621889D0 (en) | Cell | |
SG10202005876VA (en) | Cell reprogramming | |
GB201610515D0 (en) | Cell | |
GB201522097D0 (en) | Cells | |
SG10202000644TA (en) | Improved Stem Cell Composition | |
GB201603372D0 (en) | Cell | |
PT3157504T (pt) | Composições estimuladoras das células estaminais | |
PL3429689T3 (pl) | Bezkomórkowe preparaty z łożyska | |
GB201701509D0 (en) | Pluripotenet stem cells | |
ZA201900891B (en) | B-cell-mimetic cells | |
HK1253244A1 (zh) | 使用受刺激的胎盤幹細胞的血管生成 | |
GB201522223D0 (en) | Therapeutic T cells | |
GB201617716D0 (en) | Cell | |
GB201719541D0 (en) | Cell Lines | |
GB201418893D0 (en) | Monolithic body | |
HUE042287T2 (hu) | Lítium-kén cella | |
TWI560853B (en) | Cell contact structure | |
SG10201403640XA (en) | Stem cells | |
GB201621874D0 (en) | Therapeutic Cells |